Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Vasnetsov Sergey | 0001500294 | Nov-09-2022 | director |
Wider Todd | 0001642715 | Nov-09-2022 | director |
Mann Paul Elliot | 0001744816 | Nov-09-2022 | director, 10 percent owner, officer: Chief Executive Officer |
Donfeld Joshua Jay | 0001870347 | Nov-09-2022 | director |
Moore Duncan | 0001888265 | Nov-09-2022 | director |
Ronander Einar | 0001951272 | Nov-09-2022 | 10 percent owner, other: Chief Scientific Adviser |
Ainscow Robert | 0001951275 | Nov-09-2022 | officer: Chief Financial Officer |
Strydom Hendrik | 0001951278 | Nov-09-2022 | director, 10 percent owner |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ASP Isotopes Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
8-K | Document | Current report filing Acc-no: 0001477932-24-005946 (34 Act) Size: KB |
Sep-26-2024 | 241326347 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001477932-24-005650 ( Act) Size: 0 KB |
Sep-10-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001477932-24-005649 ( Act) Size: 0 KB |
Sep-10-2024 | |
8-K | Document | Current report filing Acc-no: 0001477932-24-005455 (34 Act) Size: KB |
Sep-03-2024 | 241274517 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001477932-24-005128 (34 Act) Size: KB |
Aug-19-2024 | 241221027 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001477932-24-004881 ( Act) Size: 0 KB |
Aug-14-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001477932-24-004880 ( Act) Size: 0 KB |
Aug-14-2024 | |
NT 10-Q | Document | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001477932-24-004855 (34 Act) Size: KB |
Aug-14-2024 | 241209258 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000902664-24-004969 ( Act) Size: 0 KB |
Aug-05-2024 | |
8-K | Document | Current report filing Acc-no: 0001477932-24-004217 (34 Act) Size: KB |
Jul-15-2024 | 241117450 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001477932-24-004209 ( Act) Size: 0 KB |
Jul-15-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001477932-24-004208 ( Act) Size: 0 KB |
Jul-15-2024 | |
424B5 | Document | Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001477932-24-004202 (33 Act) Size: KB |
Jul-12-2024 | 241115258 |
8-K | Document | Current report filing Acc-no: 0001477932-24-004182 (34 Act) Size: KB |
Jul-12-2024 | 241113264 |
424B5 | Document | Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001477932-24-004171 (33 Act) Size: KB |
Jul-11-2024 | 241112065 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000902664-24-004664 ( Act) Size: 0 KB |
Jul-10-2024 | |
UPLOAD | Document | Acc-no: 0000000000-24-007511 ( Act) Size: KB | Jul-02-2024 | |
10-K/A | Document | Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001477932-24-004013 (34 Act) Size: KB |
Jul-01-2024 | 241090963 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001477932-24-004011 ( Act) Size: 0 KB |
Jul-01-2024 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001477932-24-004010 ( Act) Size: 0 KB |
Jul-01-2024 |
Recent 20 filings. View all ASP Isotopes Inc. filings
Very good communication and delivery made within the timeframe I was advised of
Huge help thank you for your help .. y'all make it so much easier
Thanks I look forward to using the product to improve my skin tone
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by